Molly Davis

Background

About Molly Davis

I received my B.S. in Human Biology from Stanford University. I graduated from the University of Washington School of Medicine in 2001 and completed a general psychiatry residency and geriatric psychiatry fellowship at Oregon Health & Science University. I served as chief resident in my final year of training. I am board certified in both general and geriatric psychiatry. Following my training, I joined the faculty at OHSU as a geriatric psychiatrist, specializing in treating patients with refractory mood disorders with electroconvulsive therapy. Subsequently, I worked in various inpatient and outpatient psychiatric settings. Since 2015, my focus has been on using deep transcranial magnetic stimulation (dTMS) for treatment-resistant mental illness. Currently, I am thrilled to be partnering with Dr. Eliza Brink, PARNP + DNP, at Clear Path Psychiatry, an innovative interventional psychiatry practice in Seattle, Washington. We are proud to offer deep transcranial magnetic stimulation to treat treatment-resistant depression and obsessive-compulsive disorder, using the Brainsway H1 and H7 coils. We also offer Spravato (intranasal esketamine) as an augmenting agent for patients suffering from depression. We plan on offering intra-muscular ketamine with ketamine-assisted psychotherapy for people needing rapid relief from severe, treatment-refractory depression. In 2018, I immersed myself in studying psychedelic medicine. I am trained through the Multidisciplinary Association for Psychedelic Studies (MAPS) to offer MDMA-assisted therapy for individuals with treatment-resistant PTSD as soon as this treatment gains FDA-approval. I am currently undergoing a year-long fellowship through the Integrative Psychiatry Institute in psychedelic-assisted therapy and am eager to offer these medicines as they gain FDA-approval. Beyond my professional pursuits, my personal journey has equipped me with a unique perspective on navigating life as a patient. Having undergone treatment for triple-negative breast cancer in 2018, followed by acute myeloid leukemia and a stem-cell (bone marrow) transplant in 2020, I have a profound understanding of the challenges faced by individuals with life-threatening illnesses and those confronting mortality. I am passionate about working with people who live with life-threatening and chronic illnesses. I believe that psychedelic-assisted therapy, in particular, can help individuals find meaning, hope, and joy in their lives, even when facing their mortality.